全文获取类型
收费全文 | 3640篇 |
免费 | 283篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 68篇 |
妇产科学 | 133篇 |
基础医学 | 608篇 |
口腔科学 | 35篇 |
临床医学 | 349篇 |
内科学 | 685篇 |
皮肤病学 | 78篇 |
神经病学 | 493篇 |
特种医学 | 126篇 |
外科学 | 338篇 |
综合类 | 29篇 |
一般理论 | 5篇 |
预防医学 | 332篇 |
眼科学 | 55篇 |
药学 | 229篇 |
中国医学 | 5篇 |
肿瘤学 | 360篇 |
出版年
2024年 | 2篇 |
2023年 | 35篇 |
2022年 | 81篇 |
2021年 | 129篇 |
2020年 | 92篇 |
2019年 | 89篇 |
2018年 | 107篇 |
2017年 | 103篇 |
2016年 | 140篇 |
2015年 | 148篇 |
2014年 | 190篇 |
2013年 | 223篇 |
2012年 | 350篇 |
2011年 | 375篇 |
2010年 | 172篇 |
2009年 | 164篇 |
2008年 | 264篇 |
2007年 | 241篇 |
2006年 | 231篇 |
2005年 | 229篇 |
2004年 | 180篇 |
2003年 | 173篇 |
2002年 | 137篇 |
2001年 | 14篇 |
2000年 | 7篇 |
1999年 | 16篇 |
1998年 | 15篇 |
1997年 | 12篇 |
1996年 | 6篇 |
1995年 | 1篇 |
1993年 | 4篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1988年 | 1篇 |
1985年 | 1篇 |
1980年 | 2篇 |
1979年 | 2篇 |
排序方式: 共有3942条查询结果,搜索用时 31 毫秒
91.
Jingzhong Ding Lindsay M. Reynolds Tanja Zeller Christian Müller Kurt Lohman Barbara J. Nicklas Stephen B. Kritchevsky Zhiqing Huang Alberto de la Fuente Nicola Soranzo Robert E. Settlage Chia-Chi Chuang Timothy Howard Ning Xu Mark O. Goodarzi Y.-D. Ida Chen Jerome I. Rotter David S. Siscovick John S. Parks Susan Murphy David R. Jacobs Jr. Wendy Post Russell P. Tracy Philipp S. Wild Stefan Blankenberg Ina Hoeschele David Herrington Charles E. McCall Yongmei Liu 《Diabetes》2015,64(10):3464-3474
92.
Eyrich M Croner T Leiler C Lang P Bader P Klingebiel T Niethammer D Schlegel PG 《Blood》2002,100(5):1915-1918
Normalization of restricted T-cell-receptor (TCR) repertoire is critical following T-cell-depleted (TCD) stem cell transplantation. We present a prospective study analyzing respective contributions of naive and memory T-cell subsets within the CD4(+) and CD8(+) compartments to the evolution of overall TCR-repertoire complexity following transplantation of CD34-selected peripheral blood progenitor cells from unrelated donors. During the first year after transplantation, sorted CD4/45RA, CD4/45R0, CD8/45RA, and CD8/45R0 subsets were analyzed at 3-month intervals for TCR-repertoire complexity by CDR3 size spectratyping. Skew in TCR-repertoire was observed only in early memory-type T cells. CD4(+) and CD8(+) subsets differed in clonal distribution of CDR3 sizes, with rapid Gaussian normalization of bands in CD4/45R0(+) T cells. Naive T cells displayed normal repertoire complexity and contributed significantly to skew correction. Our data provide direct evidence for an important role of de novo maturation of naive T cells in normalization of an initially restricted TCR-repertoire following transplantation of CD34-selected, TCD-depleted peripheral blood progenitors from unrelated donors. 相似文献
93.
Andries C. Bloem Tanja Lamme Martin de Smet Henriette Kok Wim Vooijs John Wijdenes Saskia E. Boom & Henk M. Lokhorst 《British journal of haematology》1998,100(1):166-175
Long-term bone marrow cultured stromal cells (LTBMC) produce IL-6 after contact with tumour cells from multiple myeloma patients. We found that LTBMC could substitute for exogenous IL-6 in the stimulation of bone marrow plasma cells from myeloma patients with active disease in short-term cultures. In addition, tumour cells of some patients with inactive disease, which were unresponsive to exogenous IL-6, were induced to IL-6-dependent growth after LTBMC co-culture. To study the role of LTBMC in myeloma tumour growth in vitro , plasma cell lines UM-2 and UM-3 were selected. UM-2 and UM-3 grew in contact with LTBMC and proliferation was blocked by antibodies against IL-6, IL-6 receptor (IL-6R, gp80, CD126) or the common signal transducing unit, gp130 (CD130). Culture with IL-6 alone or combined with GM-CSF resulted in cell death via apoptosis. The combination of IL-6 with soluble gp80, however, maintained in vitro proliferation of UM-2 and UM-3 cells. These data imply that LTBMC regulate myeloma growth in vitro via production of IL-6, possibly via induction of a functional IL-6 receptor on the tumour cells. 相似文献
94.
95.
Daniela Münch Ina Engels Anna Müller Katrin Reder-Christ Hildegard Falkenstein-Paul Gabriele Bierbaum Fabian Grein Gerd Bendas Hans-Georg Sahl Tanja Schneider 《Antimicrobial agents and chemotherapy》2015,59(2):772-781
Oritavancin is a semisynthetic derivative of the glycopeptide antibiotic chloroeremomycin with activity against Gram-positive pathogens, including vancomycin-resistant staphylococci and enterococci. Compared to vancomycin, oritavancin is characterized by the presence of two additional residues, a hydrophobic 4′-chlorobiphenyl methyl moiety and a 4-epi-vancosamine substituent, which is also present in chloroeremomycin. Here, we show that oritavancin and its des-N-methylleucyl variant (des-oritavancin) effectively inhibit lipid I- and lipid II-consuming peptidoglycan biosynthesis reactions in vitro. In contrast to that for vancomycin, the binding affinity of oritavancin to the cell wall precursor lipid II appears to involve, in addition to the d-Ala-d-Ala terminus, other species-specific binding sites of the lipid II molecule, i.e., the crossbridge and d-isoglutamine in position 2 of the lipid II stem peptide, both characteristic for a number of Gram-positive pathogens, including staphylococci and enterococci. Using purified lipid II and modified lipid II variants, we studied the impact of these modifications on the binding of oritavancin and compared it to those of vancomycin, chloroeremomycin, and des-oritavancin. Analysis of the binding parameters revealed that additional intramolecular interactions of oritavancin with the peptidoglycan precursor appear to compensate for the loss of a crucial hydrogen bond in vancomycin-resistant strains, resulting in enhanced binding affinity. Augmenting previous findings, we show that amidation of the lipid II stem peptide predominantly accounts for the increased binding of oritavancin to the modified intermediates ending in d-Ala-d-Lac. Corroborating our conclusions, we further provide biochemical evidence for the phenomenon of the antagonistic effects of mecA and vanA resistance determinants in Staphylococcus aureus, thus partially explaining the low frequency of methicillin-resistant S. aureus (MRSA) acquiring high-level vancomycin resistance. 相似文献
96.
Marcus E. Kleber Graciela Delgado Tanja B. Grammer Günther Silbernagel Jie Huang Bernhard K. Kr?mer Eberhard Ritz Winfried M?rz 《Journal of the American Society of Nephrology : JASN》2015,26(11):2831-2838
Obesity and diets rich in uric acid–raising components appear to account for the increased prevalence of hyperuricemia in Westernized populations. Prevalence rates of hypertension, diabetes mellitus, CKD, and cardiovascular disease are also increasing. We used Mendelian randomization to examine whether uric acid is an independent and causal cardiovascular risk factor. Serum uric acid was measured in 3315 patients of the Ludwigshafen Risk and Cardiovascular Health Study. We calculated a weighted genetic risk score (GRS) for uric acid concentration based on eight uric acid–regulating single nucleotide polymorphisms. Causal odds ratios and causal hazard ratios (HRs) were calculated using a two-stage regression estimate with the GRS as the instrumental variable to examine associations with cardiometabolic phenotypes (cross-sectional) and mortality (prospectively) by logistic regression and Cox regression, respectively. Our GRS was not consistently associated with any biochemical marker except for uric acid, arguing against pleiotropy. Uric acid was associated with a range of prevalent diseases, including coronary artery disease. Uric acid and the GRS were both associated with cardiovascular death and sudden cardiac death. In a multivariate model adjusted for factors including medication, causal HRs corresponding to each 1-mg/dl increase in genetically predicted uric acid concentration were significant for cardiovascular death (HR, 1.77; 95% confidence interval, 1.12 to 2.81) and sudden cardiac death (HR, 2.41; 95% confidence interval, 1.16 to 5.00). These results suggest that high uric acid is causally related to adverse cardiovascular outcomes, especially sudden cardiac death. 相似文献
97.
Max Wagener Gino Lee Fabio Stallone Tanja Marxer Christian Puelacher Carmela Schumacher Seoung Mann Sou Raphael Twerenbold Tobias Reichlin Thomas Hochgruber Yunus Tanglay Michael Freese Damian Wild Katharina Rentsch Stefan Osswald Michael Zellweger Christian Mueller 《European journal of clinical investigation》2015,45(11):1175-1183
98.
99.
Mineralocorticoid receptor signaling reduces numbers of circulating human naïve T cells and increases their CD62L,CCR7, and CXCR4 expression
下载免费PDF全文
![点击此处可从《European journal of immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Luciana Besedovsky Barbara Linz Jan Born Tanja Lange 《European journal of immunology》2014,44(6):1759-1769
The role of mineralocorticoid receptors (MRs) in human T‐cell migration is not yet understood. We have recently shown that the MR antagonist spironolactone selectively increases the numbers of circulating naïve and central memory T cells during early sleep, which is the time period in the 24 h cycle hallmarked by predominant MR activation. To investigate whether this effect is specific to spironolactone's blockade of MRs and to study the underlying molecular mechanisms, healthy humans were given the selective MR‐agonist fludrocortisone or placebo and numbers of eight T‐cell subsets and their CD62L and CXCR4 expression were analyzed. Fludrocortisone selectively reduced counts of naïve CD4+, central memory CD4+, and naïve CD8+ T cells and increased CXCR4 expression on the naïve subsets. In complementing in vitro studies, fludrocortisone enhanced CXCR4 and CD62L expression, which was counteracted by spironolactone. Incubation of naïve T cells with spironolactone alone reduced CD62L and CCR7 expression. Our results indicate a regulatory influence of MR signaling on human T‐cell migration and suggest a role for endogenous aldosterone in the redistribution of T‐cell subsets to lymph nodes, involving CD62L, CCR7, and CXCR4. Facilitation of T‐cell homing following sleep‐dependent aldosterone release might thus essentially contribute to sleep's well‐known role in supporting adaptive immunity. 相似文献
100.
Topical rather than intradermal application of the TLR7 ligand imiquimod leads to human dermal dendritic cell maturation and CD8+ T‐cell cross‐priming
下载免费PDF全文
![点击此处可从《European journal of immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Cynthia M. Fehres Sven C. M. Bruijns Astrid J. van Beelen Hakan Kalay Martino Ambrosini Erik Hooijberg Wendy W. J. Unger Tanja D. de Gruijl Yvette van Kooyk 《European journal of immunology》2014,44(8):2415-2424
Toll‐like receptor (TLR) ligands are attractive candidate adjuvants for therapeutic cancer vaccines, since TLR signaling stimulates and tunes both humoral and cellular immune responses induced by dendritic cells (DCs). Given that human skin contains a dense network of DCs, which are easily accessible via (intra‐)dermal delivery of vaccines, skin is actively explored as an antitumor vaccination site. Here we used a human skin explant model to explore the potential of TLR ligands as adjuvants for DC activation in their complex microenvironment. We show that topical application of Aldara skin cream, 5% of which comprises the TLR7 agonist imiquimod, significantly enhanced DC migration as compared with that resulting from intradermal injection of the TLR7/8 ligand R848 or the soluble form of imiquimod. Moreover, Aldara‐treated DCs showed highest levels of the costimulatory molecules CD86, CD83, CD40, and CD70. Topical Aldara induced the highest production of pro‐inflammatory cytokines in skin biopsies. When combined with intradermal peptide vaccination, Aldara‐stimulated DCs showed enhanced cross‐presentation of the melanoma antigen MART‐1, which resulted in increased priming and activation of MART‐1‐specific CD8+ T cells. These results point to advantageous effects of combining the topical application of Aldara with antitumor peptide vaccination. 相似文献